Mesoblast (MESO) Property, Plant & Equipment (Net) Growth (3y) (2018 - 2025)
Mesoblast (MESO) Property, Plant & Equipment (Net) Growth (3y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 14.05% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 11.65% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 411.50% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 16.78% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -56.31% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.66% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 19.96% |
| 10 | Mesoblast | 2.01 Bn | 1.87 Bn | - | 4.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.84% |
| Jun 30, 2025 | -5.94% |
| Dec 31, 2024 | -25.92% |
| Jun 30, 2024 | 477.78% |
| Dec 31, 2023 | -28.75% |
| Jun 30, 2023 | -16.04% |
| Mar 31, 2023 | -8.93% |
| Dec 31, 2022 | 0.04% |
| Sep 30, 2022 | 22.23% |
| Jun 30, 2022 | 35.28% |
| Mar 31, 2022 | 39.57% |
| Dec 31, 2021 | 41.54% |
| Sep 30, 2021 | 39.36% |
| Jun 30, 2021 | 40.73% |
| Mar 31, 2021 | 33.26% |
| Dec 31, 2020 | 30.60% |
| Sep 30, 2020 | 11.93% |
| Jun 30, 2020 | 8.12% |
| Mar 31, 2020 | -3.00% |
| Dec 31, 2019 | -14.49% |